Skip to main content
Clinical Trials/JPRN-UMIN000030495
JPRN-UMIN000030495
Recruiting
未知

An exploratory study to determine the genetic polymorphisms or mutations associated with type 1 diabetes and interstitial lung disease induced by immune checkpoint inhibitor; nivolumab - An exploratory study to determine the irAE-related genes induced by immune checkpoint inhibitor; nivolumab

agasaki University Hospital0 sites130 target enrollmentDecember 21, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
type 1 diabetes interstitial lung disease
Sponsor
agasaki University Hospital
Enrollment
130
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2017
End Date
December 14, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
agasaki University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The patient whom the researcher consider to be inappropriate for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials